Sort
51,593 grants matching “hepatitis”
A targeted analytical framework to optimize posthospitalization delirium pharmacotherapy in patients with Alzheimers disease and related dementias
$833,178Joshua K Lin · Brigham And Women'S Hospital · R01 · FY2025 · AG
Adverse metabolic effects of dietary sugar _ Ad libitum vs energy-balanced diets
$832,999Peter J Havel · University Of California At Davis · R01 · FY2016 · HL
INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERS
$832,913Shruti H Mehta · Johns Hopkins University · R56 · FY2013 · DA
Reduce Transmission Risks &Improve HCV Treatment Access
$832,667Johns Hopkins University · R01 · FY2001 · DA
Mechanistic studies of nucleic acid enzymes involved in DNA replication, transcription, and innate immunity
$832,426Smita S Patel · Rbhs-Robert Wood Johnson Medical School · R35 · FY2019 · GM
Mechanistic studies of nucleic acid enzymes involved in DNA replication, transcription, and innate immunity
$832,426Smita S Patel · Rbhs-Robert Wood Johnson Medical School · R35 · FY2020 · GM
Chromatin Barriers Impacting Liver Development and Regeneration
$832,169Kenneth S Zaret · University Of Pennsylvania · R01 · FY2025 · DK
Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC)
$832,002Manal M Hassan · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA
Inhibition of hepatitis C by RNA-based therapeutics
$831,879Somagenics, Inc. · R44 · FY2005 · AI
Synthetic PreImplantation Factor (sPIF) plus hypothermia to treat neonatal brain injury
$831,440Eytan R Barnea · Bioincept, Llc · R44 · FY2024 · HD
Investigating the role of frailty on outcomes in acutely ill patients with cirrhosis undergoing liver transplantation in the acute care setting
$831,169Jennifer C. Lai · University Of California, San Francisco · R01 · FY2023 · DK
Ribosome Heterogeneity as a Mechanism for Metabolic Regulation
$830,890Jean E Schaffer · Joslin Diabetes Center · DP1 · FY2020 · DK
Mechanisms of Interferon-based Therapy and Resistance in HCV Infection
$830,823T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2012 · DK
Studies of HCV Infection And HCV-Host interactions
$830,823T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2012 · DK
Medication Adherence in Children Who Had a Liver Transplant (MALT)
$830,524Eyal Shemesh · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · DK
Fat and Iron-Corrected Quantitative MRI T1 Mapping for Evaluation of Chronic Liver Disease
$830,401Li Feng · New York University School Of Medicine · R01 · FY2025 · DK
RACIAL DIFFERENCE IN HCV/HOST INTERACTIONS
$830,206University Of Tennessee Health Sci Ctr · U19 · FY2002 · AI
Molecular Genetic Epidemiology of Primary Hepatocellular Carcinoma
$830,088Kenneth Buetow · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Xenobiotic Receptors
$830,019Frank J Gonzalez · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Xenobiotic-Metabolizing Enzymes
$830,019Frank J Gonzalez · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Small molecule-induced degradation of dengue proteins as an antiviral strategy
$829,756Priscilla Li-Ning Yang · Harvard Medical School · R01 · FY2020 · AI
Spectinomycin analogs for NTM infections
$829,725Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2022 · AI
P75 Small Molecule Ligands for Alzheimer's Therapy
$829,613Frank M Longo · Stanford University · U01 · FY2011 · AG
HCV Transmission among Young IDUs in NYC
$829,591Brian R. Edlin · Suny Downstate Medical Center · R01 · FY2011 · DA
Ultrasound-Mediated Gene Therapy for Hemophilia B
$829,490Carol H Miao · Seattle Children'S Hospital · R33 · FY2010 · HL